Paying For Gene Therapy: Biggest Cost Challenges Two To Three Years Away?
Executive Summary
Only about one-quarter of the 40 gene therapies projected to launch by the end of 2025 would have potential US patient populations of more than 50,000. But a handful of treatments could target millions of individuals.